Publicaciones en colaboración con investigadores/as de Hospital Universitario Araba (2)

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

2013

  1. Dietary restriction-resistant human tumors harboring the PIK3CA-activating mutation H1047R are sensitive to metformin

    Oncotarget, Vol. 4, Núm. 9, pp. 1484-1495